Published in Gene Therapy Weekly, June 23rd, 2011
"Although the condition has previously been subdivided into PC-1 and PC-2...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.